Skip to main content

Table 7 Study results of suppressive treatment of BV.

From: Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses

   Cure rate after
Study Treatment >1 month 3 months 6 months 12 months
Sobel 1993 [50] Oral metronidazole 7 days   25%   
  Topical clindamycin 7 days   38%   
Boris 1997* [28] Oral metronidazole 10 days (for some 3 times)     63%
Eriksson 2005** [23] Topical clindamycin 3 days + lactobacilli tampons 57%    
  Topical clindamycin 3 days + placebo tampons 60%    
Sobel 2006 [7] 10 days vaginal metronidazole + twice weekly for 4 months   43%   
  10 days vaginal metronidazole + placebo   19%   
Bradshaw 2006 [6] Oral metronidazole 7 days   46% 36% 31%
Schwebke 2007 [51] Metronidazole gel twice weekly for 6 months    33%  
Marcone 2008 [29] Oral metronidazole 7 days   71% 67%  
  Oral metronidazole 7 days + Lactobacillus rhamnosus for 2 months   88% 83%  
Larsson 2008 [13] Topical clindamycin 7 days + lactobacilli    53%  
  Topical clindamycin 7 days + placebo    39%  
Reichman 2009 [52] Triple treatment with oral nitroimidazole   65% 50%  
  21 days boric acid intravaginal and     
  Metronidazole gel 20 weeks (6 month treatment)     
Ehrnström 2010 [37] Vaginal clindamycin + 5 types of lactobacilli    50%  
Marcone 2010 [30] Oral metronidazole 7 days    74% 69%
  Oral metronidazole 7 days + Lactobacillus rhamnosus for 6 months    96% 91%
This study Oral and vaginal clindamycin + vaginal metronidazole + lactobacilli    74.6% 65.1%
*Only cured patients were followed and some were treated 3 times.     
  1. **minimum 2 menstruations periods.